These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24950702)

  • 1. COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.
    Pomianowska E; Schjølberg AR; Clausen OP; Gladhaug IP
    BMC Cancer; 2014 Jun; 14():458. PubMed ID: 24950702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
    Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
    Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
    BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.
    Pomianowska E; Grzyb K; Westgaard A; Clausen OP; Gladhaug IP
    Eur J Surg Oncol; 2012 Nov; 38(11):1043-50. PubMed ID: 22883964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
    Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
    Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
    Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
    Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors in pancreatic and ampullary cancer.
    Lemke J; Schäfer D; Sander S; Henne-Bruns D; Kornmann M
    Anticancer Res; 2014 Jun; 34(6):3011-20. PubMed ID: 24922667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival.
    Lei S; Appert HE; Nakata B; Domenico DR; Kim K; Howard JM
    Int J Pancreatol; 1995 Feb; 17(1):15-21. PubMed ID: 8568330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
    Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
    Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
    Chen SC; Shyr YM; Wang SE
    HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lymph node ratio impact survival in resected periampullary malignancies?
    Hurtuk MG; Hughes C; Shoup M; Aranha GV
    Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
    Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
    J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology.
    Morris-Stiff G; Alabraba E; Tan YM; Shapey I; Bhati C; Tanniere P; Mayer D; Buckels J; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2009 Jul; 35(7):746-50. PubMed ID: 19167859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.